Membrane-immobilized gemcitabine for cancer-targetable NK cell surface engineering
Journal of Materials Chemistry B · 2024
DOI: 10.1039/d4tb01639d ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Materials Chemistry B, 2024. Verfasst von Kyung Mu Noh und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemical & Biochemical Engineering, Dongguk University, Seoul 04620, Republic of Korea. kyobum.kim@dongguk.edu. Hauptthemen laut MEDLINE: Deoxycytidine, Gemcitabine, Killer Cells, Natural. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 69 Literaturangaben. Gefördert von: National Research Foundation of Korea.
Abstract (Originalsprache)
Lipid-gemcitabine coated NK cells via surface engineering effectively delivered prodrugs to target cells, thereby boosting NK cell-mediated antitumor efficacy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Chemical & Biochemical Engineering, Dongguk University, Seoul 04620, Republic of Korea. kyobum.kim@dongguk.edu.
ORCID-Profile: Kyobum Kim
Förderung
- National Research Foundation of Korea
Zitieren
APA
Noh, K. M., Jangid, A. K., Park, J., Kim, S., & Kim, K. (2024). Membrane-immobilized gemcitabine for cancer-targetable NK cell surface engineering. Journal of Materials Chemistry B. https://doi.org/10.1039/d4tb01639d
Vancouver
Noh KM, Jangid AK, Park J, Kim S, Kim K. Membrane-immobilized gemcitabine for cancer-targetable NK cell surface engineering. Journal of Materials Chemistry B. 2024. doi:10.1039/d4tb01639d
BibTeX
@article{Noh2024,
author = {Noh, Kyung Mu and Jangid, Ashok Kumar and Park, Jaewon and Kim, Sungjun and Kim, Kyobum},
title = {Membrane-immobilized gemcitabine for cancer-targetable NK cell surface engineering},
journal = {Journal of Materials Chemistry B},
year = {2024},
doi = {10.1039/d4tb01639d}
}
EUVIMED